Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.

Bruloy E, Sinna R, Grolleau JL, Bout-Roumazeilles A, Berard E, Chaput B.

Plast Reconstr Surg. 2019 Jan;143(1):239-250. doi: 10.1097/PRS.0000000000005111.

PMID:
30589800
2.

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.

Pharmacotherapy. 2009 Jul;29(7):784-91. doi: 10.1592/phco.29.7.784.

PMID:
19558252
3.

Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

Jackson JL, Kuriyama A, Hayashino Y.

JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505.

PMID:
22535858
4.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group.

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
5.
6.
7.

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.

Silberstein S, Mathew N, Saper J, Jenkins S.

Headache. 2000 Jun;40(6):445-50.

PMID:
10849039
8.

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):293-307.

PMID:
15836565
9.
10.
11.

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM.

Otolaryngol Head Neck Surg. 2000 Dec;123(6):669-76.

PMID:
11112955
12.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group.

Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7.

PMID:
20487038
13.

Botulinum toxin type A for the treatment of migraine.

Aurora S.

Expert Opin Pharmacother. 2006 Jun;7(8):1085-95. Review.

PMID:
16722818
14.

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.

J Neurol Sci. 2013 Aug 15;331(1-2):48-56. doi: 10.1016/j.jns.2013.05.003. Epub 2013 Jun 19.

PMID:
23790235
15.

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.

Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G.

J Headache Pain. 2011 Aug;12(4):427-33. doi: 10.1007/s10194-011-0339-z. Epub 2011 Apr 16.

16.

Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A.

Cephalalgia. 2004 Oct;24(10):838-43.

PMID:
15377314
17.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.

Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

PMID:
21883197
18.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD.

Acta Neurol Scand. 2014 Jan;129(1):61-70. doi: 10.1111/ane.12171. Epub 2013 Sep 20.

19.

Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.

Freitag FG, Diamond S, Diamond M, Urban G.

Headache. 2008 Feb;48(2):201-9. Epub 2007 Nov 28.

PMID:
18042229
20.

Botulinum toxin type A in prophylactic treatment of migraine.

Anand KS, Prasad A, Singh MM, Sharma S, Bala K.

Am J Ther. 2006 May-Jun;13(3):183-7.

PMID:
16772757

Supplemental Content

Support Center